Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Net Cash Flow: 2020-2024

Historic Net Cash Flow for Pyxis Oncology (PYXS) over the last 5 years, with Dec 2024 value amounting to $9.8 million.

  • Pyxis Oncology's Net Cash Flow rose 86.07% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year change of. This contributed to the annual value of $9.8 million for FY2024, which is 105.78% up from last year.
  • Per Pyxis Oncology's latest filing, its Net Cash Flow stood at $9.8 million for FY2024, which was up 105.78% from -$169.6 million recorded in FY2023.
  • In the past 5 years, Pyxis Oncology's Net Cash Flow registered a high of $268.1 million during FY2021, and its lowest value of -$169.6 million during FY2023.
  • Its 3-year average for Net Cash Flow is -$85.1 million, with a median of -$95.6 million in 2022.
  • As far as peak fluctuations go, Pyxis Oncology's Net Cash Flow soared by 2,425.08% in 2021, and later crashed by 135.64% in 2022.
  • Over the past 5 years, Pyxis Oncology's Net Cash Flow (Yearly) stood at -$11.5 million in 2020, then soared by 2,425.08% to $268.1 million in 2021, then tumbled by 135.64% to -$95.6 million in 2022, then tumbled by 77.53% to -$169.6 million in 2023, then skyrocketed by 105.78% to $9.8 million in 2024.